| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:3415-3423.)
© 1995 American Heart Association, Inc.
Articles |
Evaluation of Importance of Central Effects of Atenolol and Metoprolol Measured by Heart Rate Variability During Mental Performance Tasks, Physical Exercise, and Daily Life in Stable Postinfarct Patients
From The Thorax Center (Y.S.T., H.J.G.M.C., J.B., M.P.v.d.B.), Department of Cardiology, University Hospital Groningen; Cardiovascular Research Institute COEUR (A.J.M.i.V.), Department of Internal Medicine, University Hospital Rotterdam; and the Department of Experimental Psychology (G.M.), University of Groningen, The Netherlands.
Correspondence to Dr Y.S. Tuininga, The Thorax Center, Department of Cardiology, University Hospital Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.
Background Physical exercise and mental work cause alterations in cardiac autonomic control. ß-Blockers protect the heart against stress, and this effect may be in part centrally mediated. In this context, the lipophilicity of the drug would be clinically relevant.
Methods and Results Thirty postinfarct patients were randomized to receive 100 mg atenolol or 200 mg metoprolol CR in a double-blind, crossover manner, each for a 6-week period. Heart rate (HR) variability was used to study autonomic effects during mental and physical stress and to study circadian variations. Mean 24-hour HR decreased from 77±7 to 60±6 beats per minute after atenolol and to 62±6 beats per minute after metoprolol (P=.046). At baseline, mental performance tasks did not affect HR, but decreased HR variability (SDNN index from 51±26 to 30±13 milliseconds [ms], P<.001; high-frequency power from 130±143 to 110±125 ms2, P=.046; and low-frequency power from 538±447 to 290±275 ms2, P<.001). Both ß-blockers decreased HR during mental performance tasks (P<.001) and increased SDNN index and high-frequency power. Before treatment, bicycle exercise decreased HR variability; root-mean-square of successive difference decreased from 21±8 to 15±10 ms (P=.004). ß-Blockade could not prevent this decrease. No differences between atenolol and metoprolol were observed for absolute high- and low-frequency power or after adjustment for HR. Vagal blockade with methylatropine during chronic ß-blocker treatment nearly abolished all components of spectral power. HR was found to be the parameter most strongly affected by ß-blockade but not by an influence on vagal tone. No differences were found between atenolol and metoprolol.
Conclusions In stable postinfarct patients, chronic treatment with metoprolol and atenolol attenuates the reduction in HR variability induced by mental performance tasks, but the effects during exercise are limited. ß-Blockers do not appear to increase vagal tone in this stable patient group. The point of action in these patients is mainly a reduction in HR, probably due to a reduction in stress-induced sympathetic activation. Clinically significant differences between atenolol and metoprolol were absent, indicating that the degree of lipophilicity does not distinguish among the ß-blockers what their salutary effects are on HR variability during the specific challenges used.
Key Words: exercise • heart rate • infarction
This article has been cited by other articles:
 |
|
 |
|
  B. Bein, R. Hanss, J. Scholz, P. H. Tonner, H. Hemingway, M. Shipley, E. Brunner, A. Britton, M. Marmot, and M. Malik Letter Regarding Article by Hemingway et al, "Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study" * Response Circulation, December 20, 2005; 112(25): e368 - e369. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, L. G. Ermilov, L. Sha, J. H. Szurszewski, P. A. Low, and V. A. Lennon Passive Transfer of Autoimmune Autonomic Neuropathy to Mice J. Neurosci., August 11, 2004; 24(32): 7037 - 7042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, P. A. Low, and V. A. Lennon Experimental Autoimmune Autonomic Neuropathy J Neurophysiol, September 1, 2003; 90(3): 2053 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Forslund, I Bjorkander, M Ericson, C Held, T Kahan, N Rehnqvist, and P Hjemdahl Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris Heart, May 1, 2002; 87(5): 415 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Kop, R. J. Verdino, J. S. Gottdiener, S. T. O'Leary, C. N. Bairey Merz, and D. S. Krantz Changes in heart rate and heart rate variability before ambulatory ischemic events J. Am. Coll. Cardiol., September 1, 2001; 38(3): 742 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sevre, J. D. Lefrandt, G. Nordby, I. Os, M. Mulder, R. O. B. Gans, M. Rostrup, and A. J. Smit Autonomic Function in Hypertensive and Normotensive Subjects : The Importance of Gender Hypertension, June 1, 2001; 37(6): 1351 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mortara, M. T. La Rovere, G. D. Pinna, R. Maestri, S. Capomolla, and F. Cobelli Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1612 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Tjeerdsma, M T Meinardi, W T A van der Graaf, M P van den Berg, N H Mulder, H J G M Crijns, E G E de Vries, and D J van Veldhuisen Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables Heart, April 1, 1999; 81(4): 419 - 423. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. V. Hojgaard, N.-H. Holstein-Rathlou, E. Agner, and J. K. Kanters Dynamics of spectral components of heart rate variability during changes in autonomic balance Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H213 - H219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Kardos, V Long, J Bryant, J Singh, P Sleight, and B Casadei Lipophilic versus hydrophilic beta 1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction Heart, February 1, 1998; 79(2): 153 - 160. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. van den Berg, J. Haaksma, J. Brouwer, R. G. Tieleman, G. Mulder, and H. J. G. M. Crijns Heart Rate Variability in Patients With Atrial Fibrillation Is Related to Vagal Tone Circulation, August 19, 1997; 96(4): 1209 - 1216. [Abstract] [Full Text]
|
|